precedex

Generic: dexmedetomidine hydrochloride

Labeler: hospira, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name precedex
Generic Name dexmedetomidine hydrochloride
Labeler hospira, inc.
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

dexmedetomidine hydrochloride 4 ug/mL

Manufacturer
Hospira, Inc.

Identifiers & Regulatory

Product NDC 0409-1434
Product ID 0409-1434_b9ce69ad-26a2-491a-b393-66712b6f3ec0
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA021038
Listing Expiration 2027-12-31
Marketing Start 2020-09-28

Pharmacologic Class

Classes
adrenergic alpha2-agonists [moa] central alpha-2 adrenergic agonist [epc] general anesthesia [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 04091434
Hyphenated Format 0409-1434

Supplemental Identifiers

RxCUI
284397 309710 1718900 1718902 1718906 1718907 1718909 1718910 2396891 2396892
UNII
1018WH7F9I

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name precedex (source: ndc)
Generic Name dexmedetomidine hydrochloride (source: ndc)
Application Number NDA021038 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 4 ug/mL
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (0409-1434-01) / 250 mL in 1 BOTTLE
source: ndc

Packages (1)

0409-1434-01 1 BOTTLE in 1 CARTON (0409-1434-01) / 250 mL in 1 BOTTLE

Ingredients (1)

dexmedetomidine hydrochloride (4 ug/mL)

Linked Drug Pages (1)

Precedex ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "b9ce69ad-26a2-491a-b393-66712b6f3ec0", "openfda": {"unii": ["1018WH7F9I"], "rxcui": ["284397", "309710", "1718900", "1718902", "1718906", "1718907", "1718909", "1718910", "2396891", "2396892"], "spl_set_id": ["548a88c0-afda-427e-75ac-5af0cfa2224c"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (0409-1434-01)  / 250 mL in 1 BOTTLE", "package_ndc": "0409-1434-01", "marketing_start_date": "20200928"}], "brand_name": "Precedex", "product_id": "0409-1434_b9ce69ad-26a2-491a-b393-66712b6f3ec0", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]", "General Anesthesia [PE]"], "product_ndc": "0409-1434", "generic_name": "DEXMEDETOMIDINE HYDROCHLORIDE", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Precedex", "active_ingredients": [{"name": "DEXMEDETOMIDINE HYDROCHLORIDE", "strength": "4 ug/mL"}], "application_number": "NDA021038", "marketing_category": "NDA", "marketing_start_date": "20200928", "listing_expiration_date": "20271231"}